Abstract
EPHA3, a member of the EPH family, is overexpressed in various cancers. We demon-strated previously that EPHA3 is associated with radiation resistance in head and neck cancer via the PTEN/Akt/EMT pathway; the inhibition of EPHA3 significantly enhances the efficacy of radiotherapy in vitro and in vivo. In this study, we investigated the mechanisms of PTEN regulation through EPHA3-related signaling. Increased DNA methyltransferase 1 (DNMT1) and enhancer of zeste homolog 2 (EZH2) levels, along with increased histone H3 lysine 27 trimethylation (H3K27me3) levels, correlated with decreased levels of PTEN in radioresistant head and neck cancer cells. Furthermore, PTEN is regulated in two ways: DNMT1-mediated DNA methylation, and EZH2-mediated histone methylation through EPHA3/C-myc signaling. Our results suggest that EPHA3 could display a novel regulatory mechanism for the epigenetic regulation of PTEN in radi-oresistant head and neck cancer cells.
Author supplied keywords
Cite
CITATION STYLE
Kim, S. H., Kang, B. C., Seong, D., Lee, W. H., An, J. H., Je, H. U., … Han, M. W. (2021). Epha3 contributes to epigenetic suppression of pten in ra-dioresistant head and neck cancer. Biomolecules, 11(4). https://doi.org/10.3390/biom11040599
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.